The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study)

This proposed information collection supports the U.S. Food and Drug Administration’s (FDA) efforts to assess campaign effectiveness. The Center for Tobacco Products (CTP) is proposing to conduct a quantitative study of the effects of FDA’s The Real Cost campaign on youth in the U.S. The purpose of FDA’s The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 is to evaluate whether changes in key outcomes can be attributed to campaign exposure. We intend to measure self-reported campaign exposure to media advertising, which among many things, will enable FDA to assess its relationship with market-level delivery. The study will be conducted using web-based surveys that are self-administered on personal computers or web enabled mobile devices.

The latest form for The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study) expires 2026-06-30 and can be found here.

Recruitment Study Materials--Main: Baseline Recruitment & Follow-up 2 Replenishment

Federal Enterprise Architecture: Health - Consumer Health and Safety